US HB6321 | 2025-2026 | 119th Congress
Status
Sponsorship: Slight Partisan Bill (Democrat 3-1)
Status: Introduced on November 28 2025 - 25% progression
Action: 2025-11-28 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on November 28 2025 - 25% progression
Action: 2025-11-28 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XVIII of the Social Security Act to require coverage of lung cancer biomarker testing under the Medicare program.
Title
Lung Cancer Medicare Access to Precise Testing Act
Sponsors
| Rep. Josh Gottheimer [D-NJ] | Rep. Jennifer Kiggans [R-VA] | Rep. Eric Swalwell [D-CA] | Rep. Adelita Grijalva [D-AZ] |
History
| Date | Chamber | Action |
|---|---|---|
| 2025-11-28 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2025-11-28 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/119th-congress/house-bill/6321/all-info |
| Text | https://www.congress.gov/119/bills/hr6321/BILLS-119hr6321ih.pdf |
